Business Wire

Praxis Precision Medicines Launches with over $100 Million to Advance Pipeline of High Impact Therapies for Brain Disorders

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Praxis Precision Medicines, a clinical-stage, genetic neuroscience company, launched today with more than $100 million in financing since its inception from premier ...
Nasdaq

Evotec Presents Precision Medicine Platforms for Accelerated Pipeline Building at Capital Markets Day

HAMBURG, GERMANY / ACCESSWIRE / November 15, 2023 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) today presents at its Capital Markets Day how the Company is ...
Hosted on MSN

PYC Therapeutics Advances Precision Medicine Pipeline in Q3 2025

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update from PYC Therapeutics Limited ( ...
Business Insider

EQS-News: Evotec presents precision medicine platforms for accelerated pipeline building at Capital Markets Day

Evotec presents precision medicine platforms for accelerated pipeline building at Capital Markets Day 15.11.2023 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement.